| scholarly article | Q13442814 |
| P50 | author | Tetsuya Mitsudomi | Q37392624 |
| Yasushi Yatabe | Q56697495 | ||
| Takashi Takahashi | Q56945207 | ||
| Hisaaki Tanaka | Q89943146 | ||
| Shinichiro Miyoshi | Q114418794 | ||
| Kiyoshi Yanagisawa | Q116791537 | ||
| Shuta Tomida | Q116791539 | ||
| Hirotaka Osada | Q116791541 | ||
| Yoshio Tatematsu | Q116791543 | ||
| Junichi Takamizawa | Q116791547 | ||
| P2093 | author name string | Yoko Karube | |
| P433 | issue | 2 | |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 111-115 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Cancer Science | Q326125 |
| P1476 | title | Reduced expression of Dicer associated with poor prognosis in lung cancer patients | |
| P478 | volume | 96 |
| Q35683457 | 3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population |
| Q38637596 | A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease |
| Q42001759 | A distinct expression pattern of the long 3'-untranslated region dicer mRNA and its implications for posttranscriptional regulation in colorectal cancer. |
| Q37565007 | A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis |
| Q24303520 | A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells |
| Q28284233 | A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication |
| Q43666067 | A low Dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma |
| Q21135329 | A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis |
| Q37279318 | A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material. |
| Q38994476 | A network-biology perspective of microRNA function and dysfunction in cancer |
| Q37898108 | A new frontier in personalized cancer therapy: mapping molecular changes. |
| Q35035504 | A new short oligonucleotide-based strategy for the precursor-specific regulation of microRNA processing by dicer |
| Q42086195 | A precursor microRNA in a cancer cell nucleus: get me out of here! |
| Q37403741 | A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer |
| Q38241292 | Aberrant regulation and function of microRNAs in cancer. |
| Q36416496 | Ablation of Dicer leads to widespread perturbation of signaling pathways. |
| Q34186317 | Absence of DICER in monocytes and its regulation by HIV-1. |
| Q37328429 | Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value |
| Q40115732 | Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients. |
| Q34319010 | Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers |
| Q35713675 | Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer. |
| Q38770496 | Alternative splicing affects the subcellular localization of Drosha |
| Q52643918 | An NF90/NF110-mediated feedback amplification loop regulates dicer expression and controls ovarian carcinoma progression. |
| Q36580853 | Analyzing micro-RNA expression using microarrays |
| Q52846340 | Applications of Extracellular RNAs in Oncology. |
| Q37030891 | Applying small RNA molecules to the directed treatment of human diseases: realizing the potential |
| Q36356526 | Association of Polymorphic Variants of miRNA Processing Genes with Larynx Cancer Risk in a Polish Population |
| Q92238794 | Association of Polymorphisms in miRNA Processing Genes With Type 2 Diabetes Mellitus and Its Vascular Complications in a Southern Chinese Population |
| Q88938307 | Association of variants of miRNA processing genes with cervical precancerous lesion risk in a southern Chinese population |
| Q37837955 | B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage |
| Q26999304 | Can microRNAs improve the management of lung cancer patients? A clinician's perspective |
| Q36482284 | Causes and consequences of microRNA dysregulation |
| Q30684846 | Challenges for MicroRNA Microarray Data Analysis |
| Q33700293 | Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing |
| Q24683729 | Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications |
| Q35390914 | Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers |
| Q26746000 | Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers |
| Q39375743 | Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play |
| Q37006838 | Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma |
| Q37641085 | Clinicopathological and prognostic significance of the microRNA processing enzyme DICER1 mRNA expression in colorectal cancer patients |
| Q54285415 | Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. |
| Q34614754 | Concordant and discordant regulation of target genes by miR-31 and its isoforms |
| Q36866858 | CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer |
| Q38711390 | Current status on microRNAs as biomarkers for ovarian cancer |
| Q37970449 | Current trends in miRNAs and their relationship with oral squamous cell carcinoma. |
| Q42114708 | DGCR8 is essential for tumor progression following PTEN loss in the prostate |
| Q34731304 | DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma |
| Q53259152 | DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification. |
| Q38245164 | DICER1: mutations, microRNAs and mechanisms |
| Q34784235 | Deregulated expression of miR-106a predicts survival in human colon cancer patients |
| Q35833073 | Deregulation of dicer and mir-155 expression in liposarcoma. |
| Q33717233 | Development of the human cancer microRNA network |
| Q33986725 | Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients |
| Q36655150 | Dicer and microRNA expression in multiple sclerosis and response to interferon therapy |
| Q38766652 | Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison |
| Q34389645 | Dicer in immune cell development and function |
| Q39086355 | Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation |
| Q37183825 | Dicer is regulated by cellular stresses and interferons |
| Q41348887 | Dicer suppresses cytoskeleton remodeling and tumorigenesis of colorectal epithelium by miR-324-5p mediated suppression of HMGXB3 and WASF-2. |
| Q37109737 | Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α. |
| Q37262584 | Dicer, Drosha, and outcomes in patients with ovarian cancer |
| Q39200306 | Dicer-independent processing of short hairpin RNAs |
| Q42648408 | Dicer-independent, Ago2-mediated microRNA biogenesis in vertebrates |
| Q34986356 | Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. |
| Q38708768 | Dicer1 dysfunction promotes stemness and aggression in endometrial carcinoma |
| Q47558699 | Dicer1, AGO3, and AGO4 microRNA machinery genes are differentially expressed in developing female reproductive organs and overexpressed in cancerous ovaries of chickens. |
| Q34974250 | Disruption of microRNA biogenesis confers resistance to ER stress-induced cell death upstream of the mitochondrion |
| Q38172138 | Disruption of the expression and function of microRNAs in lung cancer as a result of epigenetic changes |
| Q39221132 | Down-regulation of Dicer expression in cervical cancer tissues |
| Q54431730 | Down-regulation of Dicer in hepatocellular carcinoma. |
| Q46206014 | Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer |
| Q44501009 | Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia |
| Q53084507 | Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab. |
| Q46269102 | Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis |
| Q39196781 | Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma |
| Q36333354 | Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism. |
| Q37770965 | Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway. |
| Q53466891 | Dysregulated expression of Dicer in invasive ductal breast carcinoma. |
| Q37580463 | Dysregulation of microRNA biogenesis machinery in cancer |
| Q33583053 | Dysregulation of microRNA biosynthesis enzyme Dicer plays an important role in gastric cancer progression |
| Q37779828 | Dysregulation of microRNAs in cancer: playing with fire |
| Q37793651 | Emerging complexity of microRNA generation cascades. |
| Q37264369 | Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN |
| Q37844619 | Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma |
| Q37272418 | Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. |
| Q37583650 | Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation |
| Q38239141 | Epithelial-mesenchymal transition transcription factors and miRNAs: "Plastic surgeons" of breast cancer |
| Q37144092 | Everything you wanted to know about small RNA but were afraid to ask. |
| Q21562396 | Evidence for X-chromosomal schizophrenia associated with microRNA alterations |
| Q42468331 | Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer |
| Q54154993 | Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas. |
| Q36487134 | Gene regulation by non-coding RNAs |
| Q37309427 | Genetic variants in RAN, DICER and HIWI of microRNA biogenesis genes and risk of cervical carcinoma in a Chinese population |
| Q35582415 | Genetic variants in miRNA processing genes and pre-miRNAs are associated with the risk of chronic lymphocytic leukemia |
| Q36808372 | Genetic variation in MicroRNA genes and risk of oral premalignant lesions |
| Q34448309 | Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population |
| Q34310416 | Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma |
| Q36657641 | Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer |
| Q44833373 | Growth of malignant extracranial tumors alters microRNAome in the prefrontal cortex of TumorGraft mice |
| Q98771721 | Hepatic Stellate Cells and Hepatocarcinogenesis |
| Q36414198 | High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer. |
| Q37337916 | Higher miRNA tolerance in immortal Li-Fraumeni fibroblasts with abrogated interferon signaling pathway |
| Q34628919 | Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. |
| Q34469837 | Hypoxia represses microRNA biogenesis proteins in breast cancer cells. |
| Q34433163 | Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression |
| Q37062821 | Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. |
| Q38909927 | IRF7 promotes glioma cell invasion by inhibiting AGO2 expression |
| Q33270228 | Identification of rat lung-specific microRNAs by micoRNA microarray: valuable discoveries for the facilitation of lung research |
| Q38430180 | Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles |
| Q33787896 | Impact of tiny miRNAs on cancers |
| Q41933258 | Impaired DICER1 function promotes stemness and metastasis in colon cancer. |
| Q35034871 | Impaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator Expression |
| Q37327471 | Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients. |
| Q29619594 | Impaired microRNA processing enhances cellular transformation and tumorigenesis |
| Q33924346 | Inactivation of p53 is insufficient to allow B cells and B-cell lymphomas to survive without Dicer |
| Q39319118 | Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder |
| Q34433762 | Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival |
| Q34129423 | Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype |
| Q37031910 | Investigation of miRNA biology by bioinformatic tools and impact of miRNAs in colorectal cancer--regulatory relationship of c-Myc and p53 with miRNAs |
| Q34771731 | Involvement of microRNAs in lung cancer biology and therapy |
| Q34221295 | Knock-down of core proteins regulating microRNA biogenesis has no effect on sensitivity of lung cancer cells to ionizing radiation |
| Q33781123 | Lung cancer: a modified epigenome |
| Q37755025 | Lung microRNA: from development to disease |
| Q35091639 | Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer |
| Q29615469 | Many roads to maturity: microRNA biogenesis pathways and their regulation |
| Q34310633 | Mechanisms of control of microRNA biogenesis. |
| Q36125057 | Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications |
| Q35795725 | MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis |
| Q39340562 | Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. |
| Q37608817 | Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention |
| Q99565923 | MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy |
| Q37273430 | MiR-192 directly binds and regulates Dicer1 expression in neuroblastoma |
| Q28283742 | MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis |
| Q35918962 | MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway. |
| Q37407582 | MiRNAs and cancer |
| Q37238372 | MiRNAs, epigenetics, and cancer |
| Q36677081 | MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development. |
| Q26752548 | MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment |
| Q33657886 | MicroRNA Machinery Genes as Novel Biomarkers for Cancer |
| Q53137197 | MicroRNA and cancer. |
| Q36142558 | MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review). |
| Q35738706 | MicroRNA as tools and therapeutics in lung cancer |
| Q27013841 | MicroRNA biogenesis pathways in cancer |
| Q35080416 | MicroRNA drop in the bloodstream and microRNA boost in the tumour caused by treatment with ribonuclease A leads to an attenuation of tumour malignancy |
| Q36037933 | MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review |
| Q37215297 | MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy? |
| Q36922250 | MicroRNA expression in lymphoma |
| Q34868281 | MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways |
| Q34986222 | MicroRNA in Melanoma. |
| Q34256044 | MicroRNA in lung cancer |
| Q58603497 | MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung |
| Q36517482 | MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application |
| Q35178777 | MicroRNA profiling of rats with ochratoxin A nephrotoxicity |
| Q27860962 | MicroRNA signatures in human cancers |
| Q24648543 | MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components |
| Q39139786 | MicroRNA therapeutics: towards a new era for the management of cancer and other diseases |
| Q53179822 | MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration. |
| Q86748477 | MicroRNA: A New Player for Cancer Chemoprevention |
| Q34158964 | MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer |
| Q36116268 | MicroRNAs and cancer therapeutics |
| Q37722649 | MicroRNAs and their role in gynecological tumors |
| Q36429673 | MicroRNAs as a potential magic bullet in cancer. |
| Q38434710 | MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation |
| Q35015730 | MicroRNAs as potential cancer therapeutics. |
| Q37855085 | MicroRNAs as therapeutic targets in cancer |
| Q80220517 | MicroRNAs as tumor suppressors |
| Q30437444 | MicroRNAs in cancer |
| Q37474280 | MicroRNAs in cancer: small molecules with a huge impact |
| Q36945531 | MicroRNAs in disease and potential therapeutic applications |
| Q35016914 | MicroRNAs in gene regulation: when the smallest governs it all |
| Q35552809 | MicroRNAs in mutagenesis, genomic instability, and DNA repair |
| Q92144036 | MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential |
| Q26823456 | MicroRNAs in respiratory disease. A clinician's overview |
| Q38035144 | MicroRNAs in the p53 network: micromanagement of tumour suppression |
| Q37297730 | MicroRNAs in the pathogenesis of Lung Cancer |
| Q39030847 | MicroRNAs in the thyroid. |
| Q26801435 | MicroRNAs, cancer and ionizing radiation: Where are we? |
| Q37339409 | MicroRNAs: key modulators of posttranscriptional gene expression. |
| Q26822633 | MicroRNAs: molecular features and role in cancer |
| Q36555717 | Mild hyperthermia enhances the expression and induces oscillations in the Dicer protein |
| Q28294558 | Misexpression of the Caenorhabditis elegans miRNA let-7 is sufficient to drive developmental programs |
| Q37120216 | Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? |
| Q29620776 | Modulation of microRNA processing by p53 |
| Q33634981 | Molecular mechanisms of Dicer: endonuclease and enzymatic activity |
| Q41455736 | Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo |
| Q37073604 | Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression. |
| Q24536288 | Negative regulation of nuclear divisions in Caenorhabditis elegans by retinoblastoma and RNA interference-related genes |
| Q36282223 | New perspectives on neoplasia and the RNA world |
| Q36571216 | Noncoding RNAs and Cancer. |
| Q37772496 | Novel biomarkers of metastatic cancer |
| Q26773316 | Oncogenic MicroRNAs: Key Players in Malignant Transformation |
| Q27860773 | Oncomirs - microRNAs with a role in cancer |
| Q91474385 | Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer/miR-16/JNK2/MMP-2 axis |
| Q24632574 | Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells |
| Q39020838 | Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation. |
| Q57285339 | PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer |
| Q30583504 | PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data |
| Q35944720 | Pathogenesis of glucocorticoid-induced avascular necrosis: A microarray analysis of gene expression in vitro |
| Q34803840 | Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma |
| Q42040109 | Prognostic significance of Dicer expression in hepatocellular carcinoma |
| Q28393448 | Prognostic significance of deregulated dicer expression in breast cancer |
| Q33720262 | Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer |
| Q37330716 | Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. |
| Q34728853 | Prognostic value of the MicroRNA regulators Dicer and Drosha in non-small-cell lung cancer: co-expression of Drosha and miR-126 predicts poor survival |
| Q47330310 | Prostate cancer small non-coding RNA transcriptome in Arabs |
| Q37419315 | Protein components of the microRNA pathway and human diseases |
| Q36992495 | Protein interactions and complexes in human microRNA biogenesis and function |
| Q39439499 | Proteomic consequences of a single gene mutation in a colorectal cancer model |
| Q35871679 | RETRACTED: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function |
| Q36478107 | RNA-binding protein AUF1 represses Dicer expression |
| Q37703453 | Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas |
| Q39365472 | Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in cancer cells |
| Q85888649 | Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma |
| Q91672424 | Reduced expression of miR-146a in human bronchial epithelial cells alters neutrophil migration |
| Q35575239 | Regulation of MicroRNA Biogenesis: A miRiad of mechanisms |
| Q42540826 | Regulation of miRNA processing and miRNA mediated gene repression in cancer |
| Q37110886 | Regulation of microRNA processing in development, differentiation and cancer |
| Q36685663 | Regulatory RNAs: future perspectives in diagnosis, prognosis, and individualized therapy |
| Q22250976 | Repurposing metformin: an old drug with new tricks in its binding pockets |
| Q59809183 | Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells |
| Q37687278 | Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis |
| Q47768823 | Role of Dicer1 in thyroid cell proliferation and differentiation. |
| Q37374960 | Role of MicroRNAs in lung disease |
| Q36950439 | Role of miRNA in carcinogenesis and biomarker selection: a methodological view |
| Q33559304 | Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. |
| Q38237787 | Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis. |
| Q26770485 | Role of microRNAs in chemoresistance |
| Q26829794 | SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer |
| Q37288961 | Signaling by p38 MAPK stimulates nuclear localization of the microprocessor component p68 for processing of selected primary microRNAs |
| Q37115608 | Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. |
| Q35168697 | Single-nucleotide polymorphisms of microRNA processing machinery genes are associated with risk for gastric cancer |
| Q28256626 | Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis |
| Q33835075 | Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing |
| Q37259884 | Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion |
| Q36024500 | Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs |
| Q39005277 | Suppression of Dicer increases sensitivity to gefitinib in human lung cancer cells. |
| Q90399991 | Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases |
| Q47302451 | Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation |
| Q36294516 | Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors |
| Q33828375 | Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array |
| Q37888763 | Systematic exploration of cancer-associated microRNA through functional screening assays |
| Q24597854 | The dicey role of Dicer: implications for RNAi therapy |
| Q33613310 | The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer. |
| Q37205801 | The impact of genomics in understanding human melanoma progression and metastasis |
| Q35786141 | The many faces of Dicer: the complexity of the mechanisms regulating Dicer gene expression and enzyme activities |
| Q36999777 | The microRNA (miRNA): overview of the RNA genes that modulate gene function |
| Q89700410 | The role of MicroRNAs in human cancer |
| Q37996436 | The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. |
| Q38555990 | The role of microRNAs in the pathogenesis of HIV-related lymphomas. |
| Q48111289 | The role of the miR-148/-152 family in physiology and disease. |
| Q30244001 | The roles of miRNAs as potential biomarkers in lung diseases |
| Q35816374 | The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases |
| Q37901391 | The roles of microRNAs in tumorigenesis and angiogenesis. |
| Q39253721 | The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing |
| Q36237868 | The therapeutic potential of RNA interference |
| Q37946457 | The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. |
| Q21136376 | The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex |
| Q36932908 | The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease |
| Q24651333 | Therapeutic microRNA strategies in human cancer |
| Q37378081 | Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma |
| Q33940775 | Up-regulated Dicer expression in patients with cutaneous melanoma |
| Q34577463 | Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma |
| Q35741699 | Up-regulation of matrix metalloproteinases in a mouse model of chemically induced colitis-associated cancer: the role of microRNAs |
| Q39108050 | Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A. |
| Q34517073 | Variation in dicer gene is associated with increased survival in T-cell lymphoma |
| Q36128090 | Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma |
| Q28290736 | let-7 regulates Dicer expression and constitutes a negative feedback loop |
| Q37402624 | mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer |
| Q47786478 | miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer |
| Q33685173 | miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia |
| Q39197814 | miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer |
| Q38320511 | miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma |
| Q33901567 | miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner |
| Q21245766 | miR-449 inhibits cell proliferation and is down-regulated in gastric cancer |
| Q27025496 | miRNA Deregulation in Cancer Cells and the Tumor Microenvironment |
| Q26824263 | miRNA biogenesis: biological impact in the development of cancer |
| Q37963628 | miRNA processing and human cancer: DICER1 cuts the mustard |
| Q36967297 | miRNAs and their potential for use against cancer and other diseases |
| Q38031424 | miRNAs as biomarkers in prostate cancer |
| Q39388462 | miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45. |
| Q36871580 | miRNAs in cancer: approaches, aetiology, diagnostics and therapy |
| Q33827750 | miRNAs in human cancer. |
| Q28264087 | microRNA involvement in human cancer |
| Q33893064 | microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma |
| Q34357915 | microRNAs and cancer metabolism reprogramming: the paradigm of metformin |
| Q26772746 | microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges |
| Q38638204 | microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance |
Search more.